HER2 Support Group Forums - Patients With Advanced Breast Cancer Denied Routine Access To Breakthrough Treatment,

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)

- Breast Cancer Newsfeed (https://her2support.org/vbulletin/forumdisplay.php?f=52)

- - Patients With Advanced Breast Cancer Denied Routine Access To Breakthrough Treatment, (https://her2support.org/vbulletin/showthread.php?t=58515)

News	07-08-2013 03:30 AM

Patients With Advanced Breast Cancer Denied Routine Access To Breakthrough Treatment,

Novartis today expressed great disappointment that the National Institute for Health and Care Excellence (NICE) has issued a final decision not to recommend its innovative advanced breast cancer treatment, Afinitor® (everolimus), to be available to patients on the NHS...

More...

All times are GMT -7. The time now is 12:34 PM.